SK Invests US$350 Million in U.S. Gene Therapy Firm Center for Breakthrough Medicines

SEOUL, Jan. 9 (Korea Bizwire) — SK Inc., the holding company of South Korea’s No. 3 conglomerate SK Group, said Sunday that it has invested US$350 million in the Center for Breakthrough Medicines (CBM), becoming the second-largest stakeholder of the U.S. gene therapy company. SK said the investment deal with the Philadelphia-based contract development manufacturing [...]